Dynamic Contrast Enhanced Magnetic Resonance Imaging Evaluates Early Therapeutic Effect of Anti-EMMPRIN Antibody with Cisplatin or X-radiation in Head and Neck Cancer Mouse Models

Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) showed that tumor microvascular perfusion was significantly suppressed by anti-EMMPRIN antibody alone or in combination with X-radiation or cisplatin in head and neck cancer mouse models. The early change of tumor perfusion parameters following anti-EMMPRIN therapy with/without cisplatin was significantly correlated with the tumor volume change, proliferation cell density, and microvessel density, but not when X-radiation treated group was included. Therefore DCE-MRI may be used to predict the therapeutic efficacy of anti-EMMPRIN antibody with/without cisplatin, but not with X-radiation.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.